Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercepharma.com
FiercePharma
Get the latest updates from FiercePharma directly as they happen.
Follow now 402 followers
Latest posts
Last updated about 13 hours ago
After Alzheimer's agitation nod, Axsome jacks up Auvelity's peak sales projection to $8B
about 13 hours ago
Fresh off gaining an FDA expansion for Auvelity as a treatment for...
Neurocrine cites work disruption data to make case for timely movement disorder diagnosis
about 13 hours ago
Neurocrine Biosciences has shared survey data showing how tardive dyskinesia affects the...
Pfizer delivers strong Q1 but keeps guidance steady amid COVID seasonality
about 13 hours ago
With a better-than-expected first quarter in the books, Pfizer—continuing to grapple with...
BioNTech to slash 1,860 jobs, exits sites in Germany and Singapore in major manufacturing pullback
about 13 hours ago
The German vaccine maker plans to wind down operations at a handful...
Novartis to close German manufacturing site, cutting 220 jobs
about 13 hours ago
Novartis is continuing its multiyear overhaul with new plans to shutter its...
Prolific Machines sets monoclonal antibody manufacturing record with light-controlled platform
about 15 hours ago
Though largely operating in the background until recently, Prolific Machines’ optogenetic approach...
Eyeing CAR-T autoimmune first, Kyverna hires pharma veteran as CCO
about 15 hours ago
Kyverna Therapeutics is on the cusp of a historic first: getting a...
Sanofi expands AI capabilities, investing $294M to scale Toronto hub
about 15 hours ago
Sanofi is supercharging its artificial intelligence capabilities. The French pharma is investing...
Newly formed Keenova launches ‘Don't Be a Viking’ campaign for Dupuytren’s contracture
about 16 hours ago
Created from the merger of Mallinckrodt and Endo last year, Keenova is...
Cytokinetics' Myqorzo succeeds in landmark cardiomyopathy trial
about 17 hours ago
Cytokinetics has aced a phase 3 trial of Myqorzo in patients with...
‘A concerted industry-government effort’: Strand Therapeutics CEO Jake Becraft on FDA’s IND reform and China
1 day ago
For Jake Becraft, Ph.D., the future of America’s biomedical innovation isn’t just...
SCOTUS temporarily restores online access to abortion pill after appeals court ruling
1 day ago
The U.S. Supreme Court has temporarily reinstated online access to the abortion...